Next Article in Journal
Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies
Next Article in Special Issue
Notch Signaling Regulation in Autoinflammatory Diseases
Previous Article in Journal
Augmentation of Bone Regeneration by Depletion of Stress-Induced Senescent Cells Using Catechin and Senolytics
 
 
Review
Peer-Review Record

Pleiotropic Role of Notch Signaling in Human Skin Diseases

Int. J. Mol. Sci. 2020, 21(12), 4214; https://doi.org/10.3390/ijms21124214
by Rossella Gratton 1,2,†, Paola Maura Tricarico 1,*,†, Chiara Moltrasio 3, Ana Sofia Lima Estevão de Oliveira 4, Lucas Brandão 5, Angelo Valerio Marzano 3, Luisa Zupin 1 and Sergio Crovella 1,2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2020, 21(12), 4214; https://doi.org/10.3390/ijms21124214
Submission received: 22 May 2020 / Revised: 9 June 2020 / Accepted: 11 June 2020 / Published: 13 June 2020

Round 1

Reviewer 1 Report

This is a timely written review article regarding the role of notch signaling in human skin diseases. The authors discussed skin diseases correlated to alterations in Notch signaling including Hidradenitis Suppurativa, Dowling Degos Disease, Adams-Oliver Syndrome, Psoriasis and Atopic Dermatitis. I do have some comments and suggestions to make this review more comprehensive, which are as follows:

  1. It seems to me that the Figures are generated by the authors. However, the way they are mentioned in the text, it looks like they derived the figures from the referenced paper. Please clarify and change the writing in the text to make it clear. Line : 96, 139, 235, 283, 350 etc.
  2. Discuss more about non-canonical Notch signaling. Please see these manuscripts: PMID: 25538890, PMID: 28955033 , PMID: 30030827, PMID: 31057403, PMID: 29160307 
  3. It’s nice to have a table showing the literatures highlighting the role of Notch in the pathogenesis of different skin diseases
  4. Briefly discuss the Notch therapeutics of skin diseases at least in preclinical studies (animal model).
  5. Need a reference for line 51
  6. Figure 1 and 2 can be combined into one figure

Author Response

We would like to sincerely thank the reviewers; their criticisms and valuable suggestions really helped us to render the text more readable and to ameliorate the quality of our review, which has been modified accordingly.

Please find attached the point-to-point answers to the criticisms raised by the reviewers.

 

Reviewer 1

Comments and Suggestions for Authors

This is a timely written review article regarding the role of notch signaling in human skin diseases. The authors discussed skin diseases correlated to alterations in Notch signaling including Hidradenitis Suppurativa, Dowling Degos Disease, Adams-Oliver Syndrome, Psoriasis and Atopic Dermatitis. I do have some comments and suggestions to make this review more comprehensive, which are as follows:

  1. It seems to me that the Figures are generated by the authors. However, the way they are mentioned in the text, it looks like they derived the figures from the referenced paper. Please clarify and change the writing in the text to make it clear. Line : 96, 139, 235, 283, 350 etc.

 

Response: all figures have been designed and draw by the authors. We generated all figures using Biorender.com as stated in the acknowledgments section. We have inverted in the text the order of appearance of the literature references and the mentioned figure. By doing so we intend to clarify that the figures are not derived from the referenced papers.

 

  1. Discuss more about non-canonical Notch signaling. Please see these manuscripts: PMID: 25538890, PMID: 28955033 , PMID: 30030827, PMID: 31057403, PMID: 29160307 

Response: The text has been modified as suggested and the new references have been included in the text.

 

  1. It’s nice to have a table showing the literatures highlighting the role of Notch in the pathogenesis of different skin diseases

Response: At figure 11 the image that already shows a schematic representation of the role of Notch signaling in the skin diseases, as discussed in the review, has been implemented by adding the references.

 

  1. Briefly discuss the Notch therapeutics of skin diseases at least in preclinical studies (animal model).

Response: As suggested, we added a paragraph relative to Notch therapeutics in the conclusion section.

 

  1. Need a reference for line 51

Response: We added the reference as suggested.

 

  1. Figure 1 and 2 can be combined into one figure

Response: We combined the Figure 1 and 2 into one figure (Figure 1) as suggested.

Author Response File: Author Response.docx

Reviewer 2 Report

In this complete and interesting review, the authors provide an overview on the role of Notch in skin diseases. The review is well structured and with a clear focus, especially the second part on the skin diseases is precise and coherent. Figures are nice and convey the message unambiguously. The first part on the Notch pathway on the other hand, needs additional revisions in both language and style. Some concepts are redundant between the first (Notch pathway) and the second part (skin diseases) and should be homogenized.  The manuscript can overall benefit from corrections from an English native speaker.

In details:

Text

Lines 46-48 need rephrasing

Lines 113-115 need rephrasing

Lines 614-619 the concepts have been largely described before, please homogenize

Line 67-68 the ligand is not adjacent to the receptor (but in the case of cis-inhibition)

Line 81 transcription can be activated or inhibited

Session 2.2 and 2.3 should have a more detailed title and should avoid redundancy

It is unclear why the title of the manuscript is written in capital letters

 

Figures and references

In the legend of Figure 1 “followed by” is duplicated

 Some references in the text are still in the preliminary form of draft writing (the doi/PMID number in given instead a proper listing). Please update the list.

Reference number 1 should be substituted with a more appropriate one,  such as:

doi:10.1126/science.271.5257.1826.

doi:10.1038/nature03589.

doi:10. 1038/nrm.2016.94

DOI: 10.1038/nrm2009

Author Response

We would like to sincerely thank the reviewers; their criticisms and valuable suggestions really helped us to render the text more readable and to ameliorate the quality of our review, which has been modified accordingly.

Please find attached the point-to-point answers to the criticisms raised by the reviewers.

 

 

Reviewr 2

Comments and Suggestions for Authors

In this complete and interesting review, the authors provide an overview on the role of Notch in skin diseases. The review is well structured and with a clear focus, especially the second part on the skin diseases is precise and coherent. Figures are nice and convey the message unambiguously. The first part on the Notch pathway on the other hand, needs additional revisions in both language and style. Some concepts are redundant between the first (Notch pathway) and the second part (skin diseases) and should be homogenized.  The manuscript can overall benefit from corrections from an English native speaker.

In details:

Text

Lines 46-48 need rephrasing

Response: The text was amended as suggested. 

 

Lines 113-115 need rephrasing

Response: The text was amended as suggested. 

 

Lines 614-619 the concepts have been largely described before, please homogenize

Response: The text was amended as suggested. 

 

 

Line 67-68 the ligand is not adjacent to the receptor (but in the case of cis-inhibition)

Response: The text was amended as suggested.

 

Line 81 transcription can be activated or inhibited

Response: The text was amended as suggested.

 

Session 2.2 and 2.3 should have a more detailed title and should avoid redundancy

Response: We modified the title of the session 2.2 and 2.3

 

It is unclear why the title of the manuscript is written in capital letters

Response: We modified the title letters as suggested.

 

Figures and references

In the legend of Figure 1 “followed by” is duplicated

Response: We modified as suggested

 

 Some references in the text are still in the preliminary form of draft writing (the doi/PMID number in given instead a proper listing). Please update the list.

Reference number 1 should be substituted with a more appropriate one,  such as:

doi:10.1126/science.271.5257.1826.

doi:10.1038/nature03589.

doi:10. 1038/nrm.2016.94

DOI: 10.1038/nrm2009

Response: We updated the references as suggested.

Author Response File: Author Response.docx

Back to TopTop